Anxiety Disorders often show a chronic course, even when treated with one of the various
effective treatments available. Lack of treatment effect could be due to Treatment Resistance …

BACKGROUND: Non-remission rates to pharmacotherapy for anxiety disorders are related
to higher relapse rates, decreased quality of life and greater functional impairment. Here we …

Anxiety disorders are the most prevalent psychiatric disorders in both developed and
developing regions around the globe. 1 They are also enormously costly, both in terms of …

Background Varying conceptualizations of treatment‐resistant depression (TRD) have made
translating research findings or systematic reviews into clinical practice guidelines …

Anxiety disorders are widespread psychiatric conditions with significant social and
professional disability, poor quality of life, an increased risk of suicide, and frequent …

A sizable proportion of psychiatric patients will seek clinical evaluation and treatment for
anxiety symptoms reportedly refractory to treatment. This apparent lack of response is either …

Abstract Treatment resistance affects 20–60% of patients with psychiatric disorders; and is
associated with increased healthcare burden and costs up to ten-fold higher relative to …

Treatment Resistant Anxiety Disorders: Resolving Impasses to Symptom Remission brings
together leading cognitive behavioral therapists from major theoretical orientations to …

Anxiety disorders are common in community settings and in primary and secondary medical
care. The associated societal burden is considerable, but many of those who might benefit …

Background A systematic review and meta‐analysis was conducted to explore the efficacy of
medication augmentation strategies compared to control treatments in patients who have …